Immuneering Corp Stock Investor Sentiment

IMRX Stock  USD 2.09  0.04  1.88%   
Slightly above 62% of Immuneering Corp's investor base is looking to short. The analysis of overall sentiment of trading Immuneering Corp stock suggests that many investors are alarmed at this time. Immuneering Corp's investing sentiment can be driven by a variety of factors including economic data, Immuneering Corp's earnings reports, geopolitical events, and overall market trends.
  
over six months ago at news.google.com         
Immuneering Co. Director Peter Feinberg Purchases 25000 Shares of Stock - Defense World
Google News at Macroaxis
over six months ago at investing.com         
Immuneering Corp executive acquires shares worth 4k
Investing News at Macroaxis
over six months ago at investing.com         
Immuneering Corp director buys shares worth 7,384
Investing News at Macroaxis
over six months ago at investing.com         
Immuneering Corp executive acquires 10k in company shares
Investing News at Macroaxis
over six months ago at investing.com         
Immuneering director Peter Feinberg purchases 63.7k in company stock
Investing News at Macroaxis
over six months ago at investing.com         
Acquisition by Schall Thomas J. of 2900 shares of Immuneering Corp at 2.5465 subject to Rule 16b-3
Investing News at Macroaxis
over six months ago at www.macroaxis.com         
Acquisition by Zeskind Benjamin J. of 21756 shares of Immuneering Corp at 4.68 subject to Rule 16b-3
Macroaxis News
over six months ago at www.macroaxis.com         
Acquisition by Morales Mallory of 3 shares of Immuneering Corp at 2.5455 subject to Rule 16b-3
Macroaxis News
over six months ago at investing.com         
Acquisition by Morales Mallory of 1107 shares of Immuneering Corp at 2.7179 subject to Rule 16b-3
Investing News at Macroaxis
over six months ago at investing.com         
Immuneering corp executive acquires over 10k in company stock
Investing News at Macroaxis
over six months ago at investing.com         
Immuneering Corp executive buys shares worth over 20k
Investing News at Macroaxis
over six months ago at finance.yahoo.com         
Immuneering Director Acquires 7.5 percent More Stock
Yahoo News
over six months ago at simplywall.st         
Insider Spends US183k Buying More Shares In Immuneering
Simply Wall St News at Macroaxis
over six months ago at gurufocus.com         
Immuneering Corp Director Ann Berman Acquires 57,965 Shares
Gurufocus Stories at Macroaxis
over six months ago at gurufocus.com         
Acquisition by Brett Hall of 7000 shares of Immuneering Corp at 2.86 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about Immuneering Corp that are available to investors today. That information is available publicly through Immuneering media outlets and privately through word of mouth or via Immuneering internal channels. However, regardless of the origin, that massive amount of Immuneering data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Immuneering Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Immuneering Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Immuneering Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Immuneering Corp alpha.

Immuneering Corp Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Immuneering Stock Analysis

When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.